河北省体外膜氧合开展情况调查分析  

Investigation and analysis of extracorporeal membrane oxygenation development in Hebei Province

作　　者：宋豪杰 孙艺青 田英平[1] 高恒波[1] 姚冬奇[1] 刘亮[1] 吕宝谱 肖浩[1] 孟庆冰[1] 郑拓康 张睿[1] 崔晓磊[1] Song Haojie;Sun Yiqing;Tian Yingping;Gao Hengbo;Yao Dongqi;Liu Liang;Lv Baopu;Xiao Hao;Meng Qingbing;Zheng Tuokang;Zhang Rui;Cui Xiaolei(Department of Emergency,The Second Hospital of Hebei Medical University,Hebei Shijiazhuang 050000,China)

机构地区：[1]河北医科大学第二医院急诊科,石家庄050000

出　　处：《中国体外循环杂志》2024年第4期263-267,共5页Chinese Journal of Extracorporeal Circulation

基　　金：2023年度河北省医学科学研究课题计划(20230074)。

摘　　要：目的调查近5年河北省体外膜氧合(ECMO)开展情况。方法河北省医师协会体外生命支持委员会于2024年1月1日至1月20日通过电话随访本省各地委员及各医院中心负责人,收集近5年ECMO开展情况。结果近5年ECMO开展中心数由8个上升到31个,年例数由65例上升到489例,ECMO机器数量由28台增加到100台。2023年开展ECMO的科室共计47个,其中急诊ICU有18个,ICU有21个,心内科ICU有3个,呼吸ICU有2个,心外科有3个。近5年呼吸支持和循环支持患者的住院生存率有下降趋势,2022年最低,2023年较2022年有所升高,体外心肺复苏(ECPR)患者的生存率总体有升高趋势。2023年不同适应证成人ECMO患者生存率偏低,呼吸支持患者的住院生存率为41.7%、循环支持为36.4%、ECPR患者为17.9%。2023年11个地市共开展ECMO 489例,开展最多的城市为274例,开展最少的城市为11例,ECMO生存率最高的城市为51.7%,生存率最低的城市为9%。结论近5年来河北省ECMO技术开展中心数和例数均较前明显增多,但仍存在各地区发展不平衡,生存率较国际及国内水平偏低,有待进一步完善三级医疗ECMO救治网络,加强培训与质量控制,从而推动河北省ECMO技术发展。Objective To investigate the development of extracorporeal membrane oxygenation(ECMO)in Hebei Province over the past five years.Methods The Extracorporeal Life Support Committee of Hebei Medical Association conducted telephone follow-up with committee members and hospital center leaders from various regions in the province from January 1st to January 20th,2024,to collect information on the development of ECMO over the past 5 years.Results Over the past 5 years,the number of ECMO centers has increased from 8 to 31,the annual number of cases has increased from 65 to 489,and the number of ECMO machines has increased from 28 to 100.In 2023,there were a total of 47 departments conducting ECMO,including 18 in the emergency ICU(EICU),21 in the ICU,3 in the coronary care unit(CCU),2 in the respiratory ICU(RICU),and 3 in the cardiac surgery.The hospitalization survival rate of patients with pulmonary and cardiac support has shown a downward trend in the past 5 years,with the lowest in 2022 and an increase in 2023 compared to 2022.The overall survival rate of patients undergoing extracorporeal cardiopulmonary resuscitation(ECPR)has shown an upward trend.In 2023,the survival rate of adult ECMO patients with different indications was relatively low,with hospitalization survival rates of 41.7%for pulmonary support patients,36.4%for cardiac support patients,and 17.9%for ECPR patients.In 2023,a total of 489 cases of ECMO were carried out in 11 cities,the city with the highest number of cases was 274,while the city with the lowest number of cases was 11.The city with the highest survival rate of ECMO was 51.7%,and the city with the lowest survival rate was 9%.Conclusion Over the past five years,the number of ECMO technology development centers and cases in Hebei Province have significantly increased compared to before.However,there is still an imbalance in development among different regions,and the survival rate is relatively low compared to international and domestic levels.It is necessary to further improve the three-level me

关 键 词：体外膜氧合 体外心肺复苏 住院生存率 数据收集 质量控制 

分 类 号：R654.1[医药卫生—外科学]